Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.
about
Quantifying six-minute walk induced gait deterioration with inertial sensors in multiple sclerosis subjectsThe e-MSWS-12: improving the multiple sclerosis walking scale using item response theory.High on Walking.Clinically meaningful performance benchmarks in MS: timed 25-foot walk and the real world.Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosisFactors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical database.Validity of the timed 25-foot walk as an ambulatory performance outcome measure for multiple sclerosis.Robot-assisted vs. sensory integration training in treating gait and balance dysfunctions in patients with multiple sclerosis: a randomized controlled trial.Effect of a 2-week trial of functional electrical stimulation on gait function and quality of life in people with multiple sclerosisImpact of natalizumab on ambulatory improvement in secondary progressive and disabled relapsing-remitting multiple sclerosisA personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.Natalizumab improves ambulation in relapsing-remitting multiple sclerosis: results from the prospective TIMER study and a retrospective analysis of AFFIRM.Cognitive-motor interference in multiple sclerosis: a systematic review of evidence, correlates, and consequences.Longitudinal changes in self-reported walking ability in multiple sclerosisPatient perspectives and experience with dalfampridine treatment in multiple sclerosis-related walking impairment: the step together program.Goals set after completing a teleconference-delivered program for managing multiple sclerosis fatigue.Coactivation of Lower Limb Muscles during Gait in Patients with Multiple Sclerosis1st International Symposium on Gait and Balance in MS: Gait and Balance Measures in the Evaluation of People with MSFunctional electrical stimulation through direct 4-channel nerve stimulation to improve gait in multiple sclerosis: a feasibility study.Healthcare resource use and costs of multiple sclerosis patients in Germany before and during fampridine treatment.Dalfampridine Effects Beyond Walking Speed in Multiple Sclerosis.A machine learning approach for gait speed estimation using skin-mounted wearable sensors: From healthy controls to individuals with multiple sclerosis.Safety profile of dalfampridine extended release in multiple sclerosis: 5-year postmarketing experience in the United States.The impact of slower walking speed on activities of daily living in patients with multiple sclerosis.Mobility disability and the pattern of accelerometer-derived sedentary and physical activity behaviors in people with multiple sclerosisMapping of Multiple Sclerosis Walking Scale (MSWS-12) to five-dimension EuroQol (EQ-5D) health outcomes: an independent validation in a randomized control cohortGait variability and multiple sclerosis.Factors for lower walking speed in persons with multiple sclerosis.Correlates of the timed 25 foot walk in a multiple sclerosis outpatient rehabilitation clinicMapping the 12-item multiple sclerosis walking scale to the EuroQol 5-dimension index measure in North American multiple sclerosis patients.Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patientsThe burden of uterine fibroids for African-American women: results of a national survey.Effects on Balance and Walking with the CoDuSe Balance Exercise Program in People with Multiple Sclerosis: A Multicenter Randomized Controlled Trial.The Effect of Maximal Strength Training on Strength, Walking, and Balance in People with Multiple Sclerosis: A Pilot Study.Oxygen cost of walking in persons with multiple sclerosis: disability matters, but why?The benefits of exercise training in multiple sclerosis.Commercially available accelerometry as an ecologically valid measure of ambulation in individuals with multiple sclerosis.Benefits, safety, and prescription of exercise in persons with multiple sclerosis.Neurological disability and its association with walking impairment in multiple sclerosis: brief review.Reducing falls and improving mobility in multiple sclerosis.
P2860
Q30276230-16661A7E-ACF1-453E-8C06-52A9C0D0F248Q30276511-1416FB7E-85BB-4411-BF79-DC4BCF52E91AQ30399398-F7590D54-F5AA-4086-B32E-663B9470B463Q30409473-1E174629-01F4-4E26-9C08-A621140D9AD2Q30427715-A8D4831C-150A-4B2A-A412-49058B3DEC44Q30841972-7380093C-3DDE-4970-BBF6-D72D8B27CE8BQ33605310-27C83EC1-28F6-45A8-AB6F-F30F7239D9DEQ33659708-1886B97A-9484-4345-B46E-20A4500C1132Q34376970-6EBC73AB-7106-4E87-8B84-B313195ECC92Q34544889-29D23953-6678-4B60-9EF2-D355CFF4B316Q35154139-03C7ED79-6AE5-400B-92AD-9F8838FB0150Q35194642-CBD57728-35AA-4CA9-9D1F-2C239A32A8D2Q35206796-24B94D6A-0C13-491F-89DD-108E4AAF9D51Q35560776-93DE5A58-0A43-4CDB-A910-C18ED57981A9Q35653940-F513306C-C2AA-436F-8FD0-511A540C9341Q35676401-C6E87AB2-6E88-4E0B-AF4D-A9B8CD9BCCDCQ36059899-12D91ADE-1C75-48B0-8621-D628472EB623Q36065256-0AECE239-434F-44A8-914F-86312F5837A1Q36292910-D3D6A13B-40A1-4BF4-9BA4-6C23F9CAD151Q36324315-2FF30029-73BC-4885-BD86-076C87C3FE8AQ36358368-549E3527-3435-4774-9287-A7BC50999F6DQ36389340-A6B1ABE4-867D-4D12-AF11-75B3D6A43348Q36394528-6EA42A47-A992-4089-995C-5D2DFFE7D979Q36424217-CA6F2387-D021-440F-BC82-469B14F75E8EQ36486651-DACDB2F2-AB8D-43A8-BC95-7BCC724387A7Q36557998-B5C22B08-2122-4135-87DC-EA4CA73B4FAEQ36702949-B043334E-7FB3-4BEA-AE99-72C0DCD9C02CQ36773056-D7400FBD-E62C-413A-8C6E-E42331290484Q36849571-9987D915-D150-4320-99E4-06AD7B1387C7Q36876562-6E624EAA-7812-44A0-B61C-38A4665F44A9Q36976029-948E9308-F8DF-4D59-B054-3A59EEEA9C7AQ37208097-467B9697-F688-4AF0-8FCC-93B8215C2FB2Q37500825-D175982E-0A80-4E09-838A-1D87AB128018Q37571722-A42CA5EE-40C3-444E-BEFB-D4485991EF88Q37661540-0B4B4008-2B21-47E1-911D-6C05769FB696Q38028858-91160C92-CDC7-4655-89FB-ADB3F9D89985Q38049623-D1F8ADBC-BE21-4A18-8F8D-926791DD6B38Q38270008-A72D2438-701D-41E4-9AC2-0C8CC8DBC609Q38297020-DAD1F04B-6476-4B3B-8F04-EC0FC02B28FFQ38479436-029C3F65-E867-4999-8727-C12967516346
P2860
Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Impact of walking impairment i ...... of patients and care partners.
@en
Impact of walking impairment i ...... of patients and care partners.
@nl
type
label
Impact of walking impairment i ...... of patients and care partners.
@en
Impact of walking impairment i ...... of patients and care partners.
@nl
prefLabel
Impact of walking impairment i ...... of patients and care partners.
@en
Impact of walking impairment i ...... of patients and care partners.
@nl
P2860
P1476
Impact of walking impairment i ...... of patients and care partners.
@en
P2093
Nicholas G Larocca
P2860
P304
P356
10.2165/11591150-000000000-00000
P577
2011-01-01T00:00:00Z
P5875
P6179
1030148900